RXFP1 and glioblastoma: CTRP8‐RXFP1 is emerging as a new ligand–receptor system which promotes GBM migration (Glogowska et al., 2013) and, as shown here, protects against the cytotoxic effects of the DNA alkylating drug TMZ.